|
Market Closed -
Nasdaq
06:00:00 15/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 793.74 USD | +1.57% |
|
-4.11% | +2.83% |
| Market Cap | 78.04B 67.57B 63.74B 57.82B 108B 7,456B 109B 761B 293B 3,793B 293B 287B 12,043B | P/E 2026 * |
18.1x | P/E 2027 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 70.86B 61.36B 57.88B 52.51B 98.5B 6,770B 99.3B 691B 266B 3,445B 266B 260B 10,936B | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.68x |
| Free-Float |
71.06% | Yield 2026 * |
0.5% | Yield 2027 * | 0.56% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +1.57% | ||
| 1 week | -4.11% | ||
| Current month | -0.67% | ||
| 1 month | -1.52% | ||
| 3 months | +29.67% | ||
| 6 months | +6.43% | ||
| Current year | +2.83% |
| 1 week | 779.45 |  | 821.17 |
| 1 month | 779.08 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | -4.11% | +41.74% | -3.93% | 78.04B | |
| +1.89% | +0.78% | +523.95% | +35.09% | 57.48B | |
| +2.68% | -1.68% | -17.44% | -36.27% | 57.4B | |
| +0.35% | -1.87% | -11.03% | +27.74% | 48.81B | |
| +2.38% | -0.05% | +1.49% | +157.52% | 45.5B | |
| +0.10% | -1.57% | +50.05% | -15.06% | 32.08B | |
| +0.59% | -3.60% | +47.04% | +93.65% | 24.62B | |
| +3.53% | -5.42% | -1.02% | +170.53% | 20.77B | |
| +2.24% | -1.45% | +66.12% | +103.91% | 15.75B | |
| -0.08% | -3.29% | +41.34% | +155.76% | 14.16B | |
| Average | +1.31% | -3.60% | +74.22% | +68.89% | 39.46B | |
| Weighted average by Cap. | +1.29% | -3.44% | +91.92% | +43.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.93B 14.66B 13.83B 12.54B 23.53B 1,617B 23.72B 165B 63.57B 823B 63.57B 62.17B 2,612B | 18.48B 16.01B 15.1B 13.7B 25.69B 1,766B 25.9B 180B 69.42B 899B 69.42B 67.88B 2,852B |
| Net income | 4.77B 4.13B 3.9B 3.54B 6.63B 456B 6.69B 46.54B 17.93B 232B 17.93B 17.53B 737B | 5.45B 4.72B 4.45B 4.03B 7.57B 520B 7.63B 53.09B 20.45B 265B 20.45B 20B 840B |
| Net Debt | -7.17B -6.21B -5.86B -5.31B -9.97B -685B -10.05B -69.92B -26.94B -349B -26.93B -26.34B -1,107B | -10.05B -8.71B -8.21B -7.45B -13.98B -961B -14.09B -98.03B -37.76B -489B -37.76B -36.93B -1,552B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | USD 793.74 | +1.57% | 583,205 |
| 11/09/26 | USD 781.49 | -1.48% | 443,986 |
| 10/09/26 | USD 793.26 | -1.78% | 526,911 |
| 09/09/26 | USD 807.65 | -0.33% | 621,458 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
